Search
for
Sort by
Research 271–300 of 1000+
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Regulatory T Cells in Autoimmune Diseases and their Potential
- Syphilis: today
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- 0441 Systemic autoimmune comorbidity in alopecia totalis and universalis compared with patchy alopecia areata: A retrospective cohort study
- Semaglutide and the Skin: An Overview of Current Evidence
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Bacillus Calmette-Guerin (BCG) Site Reaction After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
- Lichen planus – A refractory autoimmune disorder
- Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?
- Granzyme B in Autoimmune Skin Disease
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Association between Serum Brain-derived Neurotrophic Factor and 25-OH Vitamin D Levels with Vitamin D Receptors Gene Polymorphism (rs2228570) in Patients with Autoimmune Thyroiditis and Hypothyroidism
- Recent advances in understanding of radiation-induced skin tissue reactions with respect to acute tissue injury and late adverse effect
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Research Progress in Chronic Autoimmune Urticaria
- Depressive Disorder and Dermatological Autoimmune Diseases
- Prediction of the Development of Depression in Patients with Autoimmune Thyroiditis and Hypothyroidism
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Hair Disorders in Autoimmune Diseases
- Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS
- Natural killer cells in atopic and autoimmune diseases of the skin
- Suppression of Cutibacterium acnes-Mediated Inflammatory Reactions by Fibroblast Growth Factor 21 in Skin
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Parental Uveitis Influences Offspring With an Increased Susceptibility to the Experimental Autoimmune Uveitis